BioPro Stem Technology winner of the ESQR’s Quality Achievements Awards in London 2017
On June 4, 2017, in London (UK), the biotech company Biopro Stem Technologies received another prestigious international award in the GOLD category within the framework of the International Convention “ESQR’s Quality Achievements Awards 2017” for its high quality products and organization of the production process.
The award ceremony was organized by the European Society for Quality Research (ESQR). The event was attended by well-known business leaders, academic experts and quality specialists from Europe, Asia, North and South America, Africa and Australia.
About the annual ESQR award
The European Society for Quality Research (ESQR), based in Lausanne, Switzerland, deals with strategic issues in the field of quality management and promotes a culture of continuous improvement through annual conventions that serve as a global forum for improving quality management practices and provide an excellent opportunity to share the experiences of participants from around the world.
The ESQR award is bestowed upon companies around the world that demonstrate best practices, leadership, exemplary quality indicators, and also serve as a source of inspiration for the global business community. BioPro Stem Technologies,which has embodied all the necessary leadership qualities in the field of cellular therapy and customer service, is valued on the international market and rightfully awarded with the prestigious international Quality Achievements Awards 2017 in the GOLD category.
About BioPro Stem Technologies
The innovative approaches in the field of biotechnology and a constant desire to improve the quality of services of the company BioPro Stem Technology are well known not only in the Ukrainian, but also in the international market for more than 8 years. Thanks to the ceaseless desire to maintain high international quality standards, the company remains a constant leader in its field. The company provides services of cellular (regenerative) therapy using the patient’s own (autologous) stem cells for the treatment of:
- Type 1 and 2 diabetes;
- Liver diseases (cirrhosis);
- Diseases of the pancreas ( pancreonecrosis );
- Non-healing wounds, trophic ulcers, diabetic foot;
- And many other diseases,
As well as anti-aging therapy.
The company has developed and patented the unique ShorDiCell® technology, based on stem cells, which has a wide range of applications both for the treatment of various diseases, and for use in aesthetic medicine.
